로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |Claudin 18.2 Hot |FMC 63 Ab  |FcRn
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: 홈 > Insights
뉴스
인사이트
전시회
프로모션
GMP-grade DLL4: A Feeder-cell Alternative for Scale-up iPSC Manufacturing
GMP-grade DLL4: A Feeder-cell Alternative for Scale-up iPSC Manufacturing
2023/11/20     Read: 182
Special Topic on Deep Interpretation of GMP Product Quality--Topic 1
Special Topic on Deep Interpretation of GMP Product Quality--Topic 1
2023/11/10     Read: 204
Eliminating Cervical Cancer through HPV Vaccine Research?
Eliminating Cervical Cancer through HPV Vaccine Research?
2023/07/06     Read: 5084
Immune System Agonists – Finding the Next Immunotherapy Target
Immune System Agonists – Finding the Next Immunotherapy Target
2023/06/21     Read: 7040
Matrigengel Matrix – From Cell Culturing to Disease Modeling and Everything In-Between
Starting from cell culturing and all the way to disease modeling, basement membranes are a critical component. ACROBiosystems provides an application-validated basement membrane extract, Matrigengel Matrix.
2023/06/15     Read: 5606
Lung Cancer Biomarkers | Delta-like Ligand 3 (DLL3)
As an important target for SCLC and other tumors, multiple therapies developed around DLL3 have developed rapidly in recent years. DLL3 drugs with bispecific antibodies, monoclonal antibodies, antibody-conjugated drugs (ADC), cell therapy, and bispecific T-cell bonding agents (BiTE) have made clinic
2023/04/20     Read: 2562
Inspiring Target: Integrin α4/β7 (LPAM-1)
To accelerate the research and development of integrin-targeting drugs, ACROBiosystems has a catalog of all 24 known integrin heterodimers, including integrin α4/β7, expressed through our HEK293 platform and verified by SEC-MALS.
2023/03/15     Read: 4440
CAR-NK Cell Therapies: Not Completely CRS-proof?
With the increase in CAR-NK and the research into other CAR cell therapies, understanding the cytokine signaling pathway is a must: not only for learning the biological effects but also in the clinical space for diagnostics and treatment strategies. Identifying immune-cell specific or a set of cytok
2023/03/07     Read: 9767
CAR Expression Detection throughout Cell Therapy Development, from Start to Finish
Following the success of cell therapy in treating leukemia and other hematological disorders, next-generation CAR cell therapy research has emphasized the need for improved manufacturing and quality control standards. With the release of new FDA guidelines on CAR cell manufacturing, one key aspect i
2023/02/22     Read: 13395
Custom GMP-grade Protein Services for Cell Therapeutic Manufacturing
ACROBiosystems launches custom GMP-grade protein development services for cell therapeutic manufacturing.We strive to be the best key materials supplier with products that are structurally designed to accompany you throughout the studies needed in development,clinical research, and beyond.
2023/02/14     Read: 6618
더.

This web search service is supported by Google Inc.

totop
Call us
우리에게 전화하세요
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521
Email
이메일
order.kr@acrobiosystems.com
Fax
팩시
+1 888-377-6111
Address
주소
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook youtube

대글

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap